Low Level laser Therapy (LLLT) Cold Laser - THOR Laser

Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

Covid 19 status: We are open for Business as Usual.
Most THORiens can work from home and our live interactive, training course is available online See Course Dates.
NEW: Free Photobiomodulation Introductory 1 Hour Webinars

About THOR Photomedicine

On Star Trek when someone is injured, they are taken to sick bay where the doctor uses a laser to heal the patient instantly. We make those (just not quite as instant).

The treatment is called Photobiomodulation (PBM Therapy) previously known as Low Level Laser Therapy (LLLT) and is considered by many scientists to be "a new branch of medicine" (Dr Roberta Chow MD PhD).

Light (within certain parameters) can regenerate tissue, reduce inflammation and reduce pain. It does this by increasing cellular energy and reducing oxidative stress. These effects have been tested in over 700 clinical trials (RCT's) and thousands of laboratory studies and published in many leading journals including The Lancet, BMJ, Nature, PNAS, Spine, Muscle and Nerve, Pain, Stroke etc.

Dedicated private PBM clinics are being born every month to meet public demand for pain relief and the former head of tissue viability for Scotland Lydia Jack demonstrated that the laser paid for itself with the first patient she treated.

Already THOR has over 5,000 customers in pioneering clinics and hospitals in more than 70 countries and is the only company with FDA, CE, TGA and NATO clearance, and we are also listed on GSA, and eCAT in the United States for government purchases.

VISION

Photobiomodulation (PBM) in every department of every hospital.

MISSION

To heal and relive pain.

VALUES

Our decisions and actions must work for all stakeholders;

James Carroll, Founder, CEO at THOR Photomedicine Ltd

The company is privately owned by founder and CEO James Carroll
James Carroll LinkedIn Profile
James Carroll papers

[top]



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Regulatory approvals include FDA, TGA Australia, NATO OTAN, CE